{{Pfam_box
| Symbol = Serpin / SERPIN
| Name = 丝氨酸蛋白酶抑制剂<br />Serpin (serine protease inhibitor)
| image = serpin_(stressed).png
| width = 
| caption = 一个丝氨酸蛋白酶抑制剂（白色）与它的“反应中心环”（蓝色）结合到[[蛋白酶|蛋白酶]]（灰色）。一旦[[蛋白酶|蛋白酶]]企图[[酶催化|催化]]就将被[[酶抑制剂#不可逆性抑制|不可逆地抑制]]。({{PDB|1K9O}})
| Pfam= PF00079
| InterPro= IPR000215
| SMART= 
| Prosite = PDOC00256
| SCOP = 1hle
| TCDB = 
| OPM family= 
| OPM protein= 
| CDD = cd00172
| PDB= 
{{PDB3|1m37}}A:1-378     {{PDB3|1hle}}B:349-379   {{PDB3|1jrr}}A:1-415
{{PDB3|1by7}}A:1-415     {{PDB3|1ova}}A:1-385     {{PDB3|1uhg}}A:1-385
{{PDB3|1jti}}B:1-385     {{PDB3|1att}}B:77-433    {{PDB3|1nq9}}L:76-461
{{PDB3|1oyh}}I:76-461    {{PDB3|1e03}}L:76-461    {{PDB3|1e05}}I:76-461
{{PDB3|1br8}}L:76-461    {{PDB3|1r1l}}L:76-461    {{PDB3|1lk6}}L:76-461
{{PDB3|1ant}}L:76-461    {{PDB3|2beh}}L:76-461    {{PDB3|1dzh}}L:76-461
{{PDB3|1ath}}A:78-461    {{PDB3|1tb6}}I:76-461    {{PDB3|2ant}}I:76-461p
{{PDB3|1dzg}}I:76-461    {{PDB3|1azx}}L:76-461    {{PDB3|1jvq}}I:76-461
{{PDB3|1sr5}}A:76-461    {{PDB3|1e04}}I:76-461    {{PDB3|1xqg}}A:1-375
{{PDB3|1xu8}}B:1-375     {{PDB3|1wz9}}B:1-375     {{PDB3|1xqj}}A:1-375
{{PDB3|1c8o}}A:1-300     {{PDB3|1m93}}A:1-55      {{PDB3|1f0c}}A:1-305
{{PDB3|1k9o}}I:18-392    {{PDB3|1sek}} :18-369    {{PDB3|1atu}} :45-415
{{PDB3|1ezx}}B:383-415   {{PDB3|8api}}A:43-382    {{PDB3|1qmb}}A:49-376
{{PDB3|1iz2}}A:43-415    {{PDB3|1oo8}}A:43-415    {{PDB3|1d5s}}B:378-415
{{PDB3|7api}}A:44-382    {{PDB3|1qlp}}A:43-415    {{PDB3|1oph}}A:43-415
{{PDB3|1kct}} :44-415    {{PDB3|2d26}}A:43-382    {{PDB3|9api}}B:383-415
{{PDB3|1psi}} :47-415    {{PDB3|1hp7}}A:43-415    {{PDB3|3caa}}A:50-383
{{PDB3|1qmn}}A:43-420    {{PDB3|4caa}}B:390-420   {{PDB3|2ach}}A:47-383
{{PDB3|1as4}}A:48-383    {{PDB3|1yxa}}B:42-417    {{PDB3|1lq8}}F:376-406
{{PDB3|2pai}}B:374-406   {{PDB3|1pai}}B:374-406   {{PDB3|1jmo}}A:119-496
{{PDB3|1jmj}}A:119-496   {{PDB3|1oc0}}A:25-402    {{PDB3|1dvn}}A:25-402
{{PDB3|1b3k}}D:25-402    {{PDB3|1dvm}}D:25-402    {{PDB3|1a7c}}A:25-402
{{PDB3|1c5g}}A:25-402    {{PDB3|1db2}}B:26-402    {{PDB3|9pai}}A:25-402
{{PDB3|1lj5}}A:25-402    {{PDB3|1m6q}}A:138-498   {{PDB3|1jjo}}D:101-361
{{PDB3|1imv}}A:49-415
}}

'''丝氨酸蛋白酶抑制剂'''（{{lang-en|serpin}}；'''ser'''ine '''p'''rotease '''in'''hibitors）是具有相似结构[[蛋白质|蛋白质]]的[[蛋白质超家族|蛋白质超家族]]，它是由于蛋白酶抑制活性被识别的，和在生命的各个[[界_(生物)|界]]被发现的第一个蛋白质超家族<ref name="Silverman_2001">{{cite journal | vauthors = Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, Whisstock JC | title = The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature | journal = The Journal of Biological Chemistry | volume = 276 | issue = 36 | pages = 33293–6 | date = September 2001 | pmid = 11435447 | doi = 10.1074/jbc.R100016200 }}</ref>。英文缩写丝氨酸蛋白酶抑制剂（{{lang-en|serpin}}）最初被创造，是因为第一个丝氨酸蛋白酶抑制剂对胰凝乳蛋白酶样[[丝氨酸蛋白酶|丝氨酸蛋白酶]]（丝氨酸蛋白酶抑制剂）将要被识别的行为<ref name="Silverman_2010">{{cite journal | vauthors = Silverman GA, Whisstock JC, Bottomley SP, Huntington JA, Kaiserman D, Luke CJ, Pak SC, Reichhart JM, Bird PI | title = Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems | journal = The Journal of Biological Chemistry | volume = 285 | issue = 32 | pages = 24299–305 | date = August 2010 | pmid = 20498369 | pmc = 2915665 | doi = 10.1074/jbc.R110.112771 }}</ref><ref name="Whisstock_2010">{{cite journal | vauthors = Whisstock JC, Silverman GA, Bird PI, Bottomley SP, Kaiserman D, Luke CJ, Pak SC, Reichhart JM, Huntington JA | title = Serpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functions | journal = The Journal of Biological Chemistry | volume = 285 | issue = 32 | pages = 24307–12 | date = August 2010 | pmid = 20498368 | pmc = 2915666 | doi = 10.1074/jbc.R110.141408 }}</ref>。它们值得注意的是其动作的不同寻常的机制，它们[[酶抑制剂#不可逆抑制剂|不可逆地]]通过经历大的[[构象改变|构象改变]]，扰乱其[[活性位点|活性位点]]抑制它们的靶[[蛋白酶|蛋白酶]]<ref name="Gettins_2002">{{cite journal | vauthors = Gettins PG | title = Serpin structure, mechanism, and function | journal = Chemical Reviews | volume = 102 | issue = 12 | pages = 4751–804 | date = December 2002 | pmid = 12475206 | doi = 10.1021/cr010170 }}</ref>。与此相反，通过对于结合并阻止访问蛋白酶活性位点的蛋白酶抑制剂是更常见的{{le|竞争抑制剂|Competitive inhibition}}机制<ref name="Whisstock_2006">{{cite journal | vauthors = Whisstock JC, Bottomley SP | title = Molecular gymnastics: serpin structure, folding and misfolding | journal = Current Opinion in Structural Biology | volume = 16 | issue = 6 | pages = 761–8 | date = December 2006 | pmid = 17079131 | doi = 10.1016/j.sbi.2006.10.005 }}</ref>。

由丝氨酸蛋白酶抑制剂的蛋白酶抑制控制的一系列生物过程，包括[[凝血因子|凝血]]和[[炎症|炎症]]，因此这些蛋白质是医学研究的目标
<ref name="Stein_1995">{{cite journal | vauthors = Stein PE, Carrell RW | title = What do dysfunctional serpins tell us about molecular mobility and disease? | journal = Nature Structural Biology | volume = 2 | issue = 2 | pages = 96–113 | date = February 1995 | pmid = 7749926 | doi = 10.1038/nsb0295-96 }}</ref>。对于[[结构生物学|结构生物学]]和[[蛋白质折叠|蛋白质折叠]]研究社区，它们独特的构象变化也使它们成为研究的兴趣<ref name="Gettins_2002"/><ref name="Whisstock_2006" />。构象变化机制赋予某些优点，但是它也具有缺点：丝氨酸蛋白酶抑制剂易受到[[突变|突变]]的影响，所述突变可导致丝氨酸蛋白酶抑制剂病例如蛋白质错误折叠（Proteopathy）和形成无活性的长链[[聚合物|聚合物]]<ref name="Janciauskiene_2011">{{cite journal | vauthors = Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T | title = The discovery of α1-antitrypsin and its role in health and disease | journal = Respiratory Medicine | volume = 105 | issue = 8 | pages = 1129–39 | date = August 2011 | pmid = 21367592 | doi = 10.1016/j.rmed.2011.02.002 }}</ref><ref name="Carrell_1997">{{cite journal | vauthors = Carrell RW, Lomas DA | title = Conformational disease | journal = Lancet | volume = 350 | issue = 9071 | pages = 134–8 | date = July 1997 | pmid = 9228977 | doi = 10.1016/S0140-6736(97)02073-4 }}</ref>。丝氨酸蛋白酶抑制剂[[聚合|聚合]]不仅减少活性抑制剂的量，而且导致聚合物的积聚，引起[[细胞死亡|细胞死亡]]和[[器官衰竭|器官衰竭]]<ref name="Stein_1995"/>。

虽然大多数丝氨酸蛋白酶抑制剂控制[[蛋白酶解|蛋白酶解]]级联，但一些具有丝氨酸蛋白酶抑制剂结构的蛋白质并不是[[酶抑制剂|酶抑制剂]]，而是执行多样化的功能，例如{{le|储藏蛋白|Storage protein|储藏}}（例如[[蛋白|蛋白]]-{{le|卵清蛋白|Ovalbumin}}），运输例如激素[[载体蛋白|载体蛋白]]（[[甲状腺素结合球蛋白|甲状腺素结合球蛋白]]，{{le|皮质激素传递球蛋白|Transcortin}}）和[[分子伴侣|分子伴侣]]（{{le|热休克蛋白47|Heat shock protein 47|HSP47}}）<ref name="Law_2006">{{cite journal | vauthors = Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI, Whisstock JC | title = An overview of the serpin superfamily | journal = Genome Biology | volume = 7 | issue = 5 | pages = 216 | year = 2006 | pmid = 16737556 | pmc = 1779521 | doi = 10.1186/gb-2006-7-5-216 }}</ref>。术语“丝氨酸蛋白酶抑制剂”也被用于描述这些成员，尽管它们具有非抑制功能，因为它们在进化上是相关的<ref name="Silverman_2001" />。

== 历史 ==
首先在1800年代末期报道了血浆中的蛋白酶抑制活性<ref>{{cite journal | last1 = Fermi | first1 = C | last2 = Personsi | first2 = L | name-list-format = vanc | title = Untersuchungen uber die enzyme, Vergleichende Studie | trans-title = Studies on the enzyme, Comparative study | language = de | journal = Z Hyg Infektionskr | date = 1984 | issue = 18 | pages = 83–89 }}</ref>，但是直到1950年代，丝氨酸蛋白酶抗凝血酶和α1-抗胰蛋白酶才被分离出<ref>{{cite journal | last1 = Schultz | first1 = H | last2 = Guilder | first2 = I | last3 = Heide | first3 =K | last4 = Schoenenberger | first4 = M | last5 = Schwick | first5 = G | name-list-format = vanc | title = Zur Kenntnis der alpha-globulin des menschlichen normal serums | trans-title = For knowledge of the alpha - globulin of human normal serums | language = de | journal = Naturforsch | date = 1955 | issue = 10 | page = 463 }}</ref>。最初的研究集中在它们在人类疾病中的作用：α1-抗胰蛋白酶缺乏是最常见的遗传疾病之一，引起[[慢性阻塞性肺病|肺气肿]]<ref name="Janciauskiene_2011"/><ref name="Laurell_2013">{{cite journal | vauthors = Laurell CB, Eriksson S | title = The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963 | journal = Copd | volume = 10 Suppl 1 | issue = | pages = 3–8 | year = 2013 | pmid = 23527532 | doi = 10.3109/15412555.2013.771956 }}</ref><ref name="de_Serres_2002">{{cite journal | last1 = de Serres | first1 = Frederick J. | name-list-format = vanc | title = Worldwide Racial and Ethnic Distribution of α-Antitrypsin Deficiency | journal = CHEST Journal | date = 1 November 2002 | volume = 122 | issue = 5 | pages = 1818–1829 | doi = 10.1378/chest.122.5.1818 }}</ref>，而抗凝血酶缺乏导致[[血栓形成|血栓形成]]<ref>{{cite journal | vauthors = Egeberg O | title = Inherited antithrombin deficiency causing thrombophilia | journal = Thrombosis Et Diathesis Haemorrhagica | volume = 13 | pages = 516–30 | date = June 1965 | pmid = 14347873 }}</ref><ref name="Patnaik MM 2516">{{cite journal | vauthors = Patnaik MM, Moll S | title = Inherited antithrombin deficiency: a review | journal = Haemophilia | volume = 14 | issue = 6 | pages = 1229–39 | date = November 2008 | pmid = 19141163 | doi = 10.1111/j.1365-2516.2008.01830.x }}</ref>。

在1980年代，才清楚这些抑制剂是包括蛋白酶抑制剂（例如α1-抗胰蛋白酶）和非抑制性成员（例如{{le|卵白蛋白|Ovalbumin}}<ref name="Hunt_1980">{{cite journal | vauthors = Hunt LT, Dayhoff MO | title = A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor | journal = Biochemical and Biophysical Research Communications | volume = 95 | issue = 2 | pages = 864–71 | date = July 1980 | pmid = 6968211 | doi = 10.1016/0006-291X(80)90867-0 }}</ref>）的相关的蛋白超家族的一部分。其名称“丝氨酸蛋白酶抑制剂” (serpin, '''ser'''ine '''p'''rotease '''in'''hibitors)是基于超家族（丝氨酸蛋白酶抑制剂）最常见的活性而创造的<ref name="Hunt_1980"/>。大约在同一时间，第一个丝氨酸蛋白酶抑制蛋白[[蛋白質三級結構|结构]]被解决了（首先在放松的构象，后来在应激构象）<ref name="Huber_1984">{{cite journal | vauthors = Loebermann H, Tokuoka R, Deisenhofer J, Huber R | title = Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function | journal = Journal of Molecular Biology | volume = 177 | issue = 3 | pages = 531–57 | date = August 1984 | pmid = 6332197 | doi = 10.1016/0022-2836(84)90298-5 }}</ref><ref name="Stein_1990">{{cite journal | vauthors = Stein PE, Leslie AG, Finch JT, Turnell WG, McLaughlin PJ, Carrell RW | title = Crystal structure of ovalbumin as a model for the reactive centre of serpins | journal = Nature | volume = 347 | issue = 6288 | pages = 99–102 | date = September 1990 | pmid = 2395463 | doi = 10.1038/347099a0 }}</ref>。结构表明抑制机制涉及异常的构象变化，并促使后续的丝氨酸蛋白酶抑制剂研究聚焦在[[结构生物学|结构]]上<ref name="Whisstock_2006">{{cite journal | vauthors = Whisstock JC, Bottomley SP | title = Molecular gymnastics: serpin structure, folding and misfolding | journal = Current Opinion in Structural Biology | volume = 16 | issue = 6 | pages = 761–8 | date = December 2006 | pmid = 17079131 | doi = 10.1016/j.sbi.2006.10.005 }}</ref><ref name="Stein_1990"/>。

现在已经鉴定了超过1000种丝氨酸蛋白酶抑制剂，包括36种人类蛋白质，以及所有[[界_(生物)|生物界]]中的分子--[[动物|动物]]，[[植物|植物]]，[[真菌|真菌]]，[[细菌|细菌]]和[[古菌|古菌]]以及一些[[痘病毒科|病毒]]的<ref name="Irving_2000"/><ref name="Irving_2002"/><ref name="Steenbakkers_2008">{{cite journal | vauthors = Steenbakkers PJ, Irving JA, Harhangi HR, Swinkels WJ, Akhmanova A, Dijkerman R, Jetten MS, van der Drift C, Whisstock JC, Op den Camp HJ | title = A serpin in the cellulosome of the anaerobic fungus Piromyces sp. strain E2 | journal = Mycological Research | volume = 112 | issue = Pt 8 | pages = 999–1006 | date = August 2008 | pmid = 18539447 | doi = 10.1016/j.mycres.2008.01.021 }}</ref>。在2000年代，一个系统命名法被引入，以便根据其进化关系对丝氨酸蛋白酶抑制剂超家族成员进行分类<ref name="Silverman_2001">{{cite journal | vauthors = Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, Whisstock JC | title = The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature | journal = The Journal of Biological Chemistry | volume = 276 | issue = 36 | pages = 33293–6 | date = September 2001 | pmid = 11435447 | doi = 10.1074/jbc.R100016200 }}</ref>。因此，丝氨酸蛋白酶抑制剂是蛋白酶抑制剂中最大的和最多样的超家族<ref name="Rawlings_2004">{{cite journal | vauthors = Rawlings ND, Tolle DP, Barrett AJ | title = Evolutionary families of peptidase inhibitors | journal = The Biochemical Journal | volume = 378 | issue = Pt 3 | pages = 705–16 | date = March 2004 | pmid = 14705960 | pmc = 1224039 | doi = 10.1042/BJ20031825 }}</ref>。

== 参考资料 ==
{{reflist|2}}

== 参阅 ==
{{portal box|药理学|分子与细胞生物学}}
* [[蛋白酶抑制剂|蛋白酶抑制剂]]

== 外部链接 ==
{{div col|2}}
* {{PDB Molecule of the Month|53|Serpin}}
* {{En}}[http://merops.sanger.ac.uk/cgi-bin/famsum?family=I4 Merops protease inhibitor claudication (Family I4)]{{Wayback|url=http://merops.sanger.ac.uk/cgi-bin/famsum?family=I4 |date=20161208210702 }}
* {{En}}{{MeshName|Serpins}}
* {{En}}[https://whisstock-lab.med.monash.edu.au/ James Whisstock laboratory]{{Wayback|url=https://whisstock-lab.med.monash.edu.au/ |date=20200308001548 }} [[莫纳什大學|莫纳什大學]] (Monash University)
* {{En}}[https://web.archive.org/web/20161030180728/http://huntingtonlab.cimr.cam.ac.uk/ Jim Huntington laboratory] [[剑桥大学|剑桥大学]]（University of Cambridge）
* {{En}}[https://web.archive.org/web/20161121042631/https://www.med.unc.edu/pharm/people/joint-faculty/frank-church-1 Frank Church laboratory] [[北卡罗来纳大学教堂山分校|北卡罗来纳大学教堂山分校]]
* {{En}}[https://web.archive.org/web/20060504050207/http://pharm.kuleuven.be/biotech/index.htm Paul Declerck laboratory] [[荷语天主教鲁汶大学|荷语天主教鲁汶大学]](Katholieke Universiteit Leuven)
* {{En}}[http://sydney.edu.au/agriculture/academic_staff/tom.roberts.php Tom Roberts laboratory]{{Wayback|url=http://sydney.edu.au/agriculture/academic_staff/tom.roberts.php |date=20170110092751 }} [[悉尼大學|悉尼大學]]
* {{En}}[http://www.weizmann.ac.il/plants/fluhr/ Robert Fluhr laboratory]{{Wayback|url=http://www.weizmann.ac.il/plants/fluhr/ |date=20141019074048 }} [[魏茨曼科學研究學院|魏茨曼科學研究學院]]
* {{En}}[http://bcmg.com.uic.edu/faculty/gettins_peter.html Peter Gettins laboratory]{{Wayback|url=http://bcmg.com.uic.edu/faculty/gettins_peter.html |date=20151009191334 }} at [[伊利諾大學芝加哥分校|伊利諾大學芝加哥分校]]
{{div col end}}

[[Category:丝氨酸蛋白酶抑制剂|Category:丝氨酸蛋白酶抑制剂]]
[[Category:蛋白质超家族|Category:蛋白质超家族]]